Overall, our findings support the prime importance of the pro-inflammatory cytokine IL-1β and of CRP in inflammation-associated schizophrenia and implicate altered expression of regulatory NF-κB pathway mRNAs in driving peripheral inflammation, and possibly cognitive impairment, in a substantial proportion of patients with schizophrenia. Here, IL1B is linked to Cognitive impairment.